Compared with non-carriers, patients with BRCA1/2 mutation have a higher risk for contralateral breast cancer with BRCA1-mutation is associated with higher risk compared to those with BRCA2. Several studies had compared outcomes of women who underwent risk-reducing mastectomies with those who opted to continue on surveillance (43). Here, BRCA1 is linked to breast cancer.